These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2013901)

  • 21. Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study.
    Krause K; Mahamed A; Weller K; Metz M; Zuberbier T; Maurer M
    J Allergy Clin Immunol; 2013 Sep; 132(3):751-754.e5. PubMed ID: 23711544
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy.
    Worm M; Muche M; Schulze P; Sterry W; Kolde G
    Br J Dermatol; 1998 Oct; 139(4):704-7. PubMed ID: 9892919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline.
    Nürnberg W; Grabbe J; Czarnetzki BM
    Acta Derm Venereol; 1995 Jan; 75(1):54-6. PubMed ID: 7747536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urticarial vasculitis secondary to H1N1 vaccination.
    Hughes R; Lacour JP; Baldin B; Reverte M; Ortonne JP; Passeron T
    Acta Derm Venereol; 2010 Nov; 90(6):651-2. PubMed ID: 21057759
    [No Abstract]   [Full Text] [Related]  

  • 25. Normocomplementemic urticarial vasculitis in a young female with persistent joint pain.
    Haque EK; Zaayman M; DeCrescenzo A; Menter A
    Int J Dermatol; 2023 Jan; 62(1):e25-e27. PubMed ID: 34865228
    [No Abstract]   [Full Text] [Related]  

  • 26. Urticarial vasculitis in a COVID-19 recovered patient.
    Nasiri S; Dadkhahfar S; Abasifar H; Mortazavi N; Gheisari M
    Int J Dermatol; 2020 Oct; 59(10):1285-1286. PubMed ID: 32880937
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous lesions and finger clubbing uncovering hypocomplementemic urticarial vasculitis and hepatitis C with mixed cryoglobulinemia.
    Pinto-Almeida T; Caetano M; Alves R; Selores M
    An Bras Dermatol; 2013; 88(6):973-6. PubMed ID: 24474109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
    Highet AS
    Br J Dermatol; 1980 Mar; 102(3):358-60. PubMed ID: 7370185
    [No Abstract]   [Full Text] [Related]  

  • 29. Urticarial vasculitis from simvastatin: what is the alternative drug?
    Bellini V; Assalve D; Lisi P
    Dermatitis; 2010; 21(4):223-4. PubMed ID: 20646678
    [No Abstract]   [Full Text] [Related]  

  • 30. Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.
    Cherrez-Ojeda I; Vanegas E; Felix M; Mata VL; Cherrez A
    BMC Dermatol; 2018 Oct; 18(1):8. PubMed ID: 30359231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urticarial vasculitis: a retrospective study of 15 cases.
    Moreno-Suárez F; Pulpillo-Ruiz Á; Zulueta Dorado T; Conejo-Mir Sánchez J
    Actas Dermosifiliogr; 2013 Sep; 104(7):579-85. PubMed ID: 23891451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normocomplementemic urticarial vasculitis secondary to Lyme disease: A rare association with challenging treatment.
    Teles C; Gaspar E; Gonçalo M; Santos L
    J R Coll Physicians Edinb; 2023 Mar; 53(1):27-29. PubMed ID: 36519641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypocomplementaemic urticarial vasculitis with bullous lesions and pericardial involvement].
    Kervarrec T; Binois R; Bléchet C; Estève É
    Ann Dermatol Venereol; 2015 Oct; 142(10):557-62. PubMed ID: 25613197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Challenging Case of Subcutaneous and Mucosal Haemorrhage Caused by Urticarial Vasculitis (Urticaria Haemorrhagica Profunda).
    Simonsen AB; Larsen MH; von Buchwald C; Kofoed K
    Acta Derm Venereol; 2020 Feb; 100(4):adv00052. PubMed ID: 31993673
    [No Abstract]   [Full Text] [Related]  

  • 35. [McDuffie hypocomplementemic urticarial vasculitis. Two cases and review of the literature].
    el Maghraoui A; Abouzahir A; Mahassine F; Tabache F; Bezza A; Ghafir D; Ohayon V; Archane MI
    Rev Med Interne; 2001 Jan; 22(1):70-4. PubMed ID: 11218302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
    Batioğlu F; Taner P; Aydintuğ OT; Heper AO; Ozmert E
    Cutan Ocul Toxicol; 2006; 25(4):281-5. PubMed ID: 17162415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory Normocomplementemic Urticarial Vasculitis Showing a Good Response to B-Cell Depletion Therapy.
    Adwan M; Hanbali R; Farah RI
    J Clin Rheumatol; 2021 Dec; 27(8S):S474-S475. PubMed ID: 31743269
    [No Abstract]   [Full Text] [Related]  

  • 38. Correct approach in urticarial vasculitis made early diagnosis of lupus nephritis possible: a case report.
    Smets K; Van Baelen A; Sprangers B; De Haes P
    J Med Case Rep; 2022 Aug; 16(1):314. PubMed ID: 35989318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urticarial vasculitis occurring in association with visceral malignancy.
    Lewis JE
    Acta Derm Venereol; 1990; 70(4):345-7. PubMed ID: 1977264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formaldehyde-induced urticarial vasculitis.
    Pellizzari M; Marshman G
    Australas J Dermatol; 2007 Aug; 48(3):174-7. PubMed ID: 17680969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.